Prognostic factors in idiopathic membranous nephropathy

被引:112
作者
Reichert, LJM [1 ]
Koene, RAP [1 ]
Wetzels, JFM [1 ]
机构
[1] Univ Nijmegen Hosp, Dept Med, Div Nephrol, NL-6500 HB Nijmegen, Netherlands
关键词
membranous nephropathy; kidney failure; prognostic factors;
D O I
10.1053/ajkd.1998.v31.pm9428445
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Membranous nephropathy is the most frequent cause of glomerulonephritis in adults with nephrotic syndrome, Approximately one quarter of the patients develop end-stage renal disease, Another quarter enters complete remission during follow-up, Treating all patients with membranous nephropathy with immunosuppressive drugs would unnecessarily expose at least one quarter of the patients to these toxic drugs, Identifying patients at highest risk would allow tailor-made treatment, Many risk factors have been found, such as male sex, HLA type DR3+/B8+, white race, advanced age, and tubulointerstitial changes or focal sclerosis found with renal biopsy, In addition, nephrotic syndrome, elevation of immunoglobulin G excretion or beta(2)-microglobulin excretion, low serum albumin, high serum cholesterol, an elevation of urinary excretion of complement activation products, impaired renal function at diagnosis, and, finally, hypertension are associated with a higher risk of renal function deterioration during follow-up, We have critically reviewed the literature and summarized the clinical significance of the above-mentioned risk factors in predicting subsequent renal function deterioration in patients with membranous nephropathy. (C) 1998 by the National Kidney Foundation, Inc.
引用
收藏
页码:1 / 11
页数:11
相关论文
共 74 条
[1]   IDIOPATHIC MEMBRANOUS GLOMERULONEPHRITIS - ASPECTS OF GEOGRAPHICAL DIFFERENCES [J].
ABE, S ;
AMAGASAKI, Y ;
KONISHI, K ;
KATO, E ;
IYORI, S ;
SAKAGUCHI, H .
JOURNAL OF CLINICAL PATHOLOGY, 1986, 39 (11) :1193-1198
[2]   SIGNIFICANCE OF TUBULOINTERSTITIAL LESIONS IN BIOPSY SPECIMENS OF GLOMERULONEPHRITIC PATIENTS [J].
ABE, S ;
AMAGASAKI, Y ;
IYORI, S ;
KONISHI, K ;
KATO, E ;
SAKAGUCHI, H .
AMERICAN JOURNAL OF NEPHROLOGY, 1989, 9 (01) :30-37
[3]  
BEREGI E, 1974, CLIN NEPHROL, V6, P215
[4]   URINARY C3DG AND C5B-9 INDICATE ACTIVE IMMUNE DISEASE IN HUMAN MEMBRANOUS NEPHROPATHY [J].
BRENCHLEY, PE ;
COUPES, B ;
SHORT, CD ;
ODONOGHUE, DJ ;
BALLARDIE, FW ;
MALLICK, NP .
KIDNEY INTERNATIONAL, 1992, 41 (04) :933-937
[5]  
BRENCHLEY PEC, 1992, NEPHROL DIAL TRANSPL, V7, P21
[6]  
CAMERON JS, 1979, KIDNEY INT, V15, P88
[7]   THE MEDICAL-RESEARCH-COUNCIL TRIAL OF SHORT-TERM HIGH-DOSE ALTERNATE DAY PREDNISOLONE IN IDIOPATHIC MEMBRANOUS NEPHROPATHY WITH NEPHROTIC SYNDROME IN ADULTS [J].
CAMERON, JS ;
HEALY, MJR ;
ADU, D .
QUARTERLY JOURNAL OF MEDICINE, 1990, 74 (274) :133-156
[8]  
Cattran D C, 1996, Curr Opin Nephrol Hypertens, V5, P427, DOI 10.1097/00041552-199609000-00009
[9]  
CATTRAN DC, 1992, NEPHROL DIAL TRANSPL, V7, P48
[10]   Validation of a predictive model of idiopathic membranous nephropathy: Its clinical and research implications [J].
Cattran, DC ;
Pei, Y ;
Greenwood, CMT ;
Ponticelli, C ;
Passerini, P ;
Honkanen, E .
KIDNEY INTERNATIONAL, 1997, 51 (03) :901-907